11/6/2013 9:44:41 AM
On behalf of Quotient Clinical I would like to invite you to a one-to-one with Mark Egerton, CEO of Quotient Clinical, at this year’s American Association of Pharmaceutical Sciences (AAPS) Meeting and Exposition in San Antonio, Texas, USA on either Tuesday 12th or Wednesday 13th November. Quotient Clinical offers a unique service, based on the Translational Pharmaceutics™ platform, that integrates early drug development and formulation with clinical testing, significantly reducing the time and cost of bringing a drug to market.
Translational Pharmaceutics brings innovation to early development via the integration of pharmaceutical development, GMP manufacture and GCP clinical testing capabilities. Drug products can be manufactured in real time immediately prior to clinical testing creating the opportunity to select formulation compositions in response to emerging clinical data (safety, pharmacokinetics, pharmacodynamics).
Also at the AAPS, Quotient Clinical will be hosting their 2nd RapidFACT (Rapid Formulation development And Clinical Testing) User Group Meeting in the morning on Tuesday 12th November and additionally Dr Alyson Connor, Director Exploratory Clinical Pharmacology will deliver a presentation on the role that imaging can play in assessing in vivo drug product performance on 14th November.
Please get in touch with me if you would like to secure your exclusive interview time with Quotient Clinical at the AAPS, otherwise I will be in touch very shortly to arrange.
Help employers find you! Check out all the jobs and post your resume.
comments powered by